Cordis Looks To Regain Previous Innovation Edge With Drug-Eluting Balloons
Executive Summary
Medtech Insight followed-up with Cordis CEO Shar Matin to talk about the company’s path forward as an innovative intervention company following the acquisition of MedAlliance.